Frontiers in Cellular and Infection Microbiology

Original Research

Published on 09 Feb 2026

A computational pipeline to discover potential cross-reactive antibodies: a case study on coronavirus

in Microbial Vaccines

Li Ye
Mengdie Hu
Yuan Wang
Zihao Li
Yewei Cun
Kailin Tang
Zhiwei Cao

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2026.1692727

484 views

Original Research

Published on 02 Feb 2026

Diphtheria-tetanus-acellular pertussis vaccine safety in children under 7 years: a post-marketing analysis of the U.S. vaccine adverse event reporting system

in Microbial Vaccines

Meishen Liu
Xueying Zhou
Linshu Guan
Hening Sun
Zhaohui Bai
Yalin Xi
Xinkuo Zheng

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2026.1733777

681 views

Original Research

Published on 27 Jan 2026

Risk signal assessment of Tdap vaccine use alone by pregnant women: An updated pharmacoepidemiological study

in Microbial Vaccines

Rujuan Fan
Zhijuan Zhu
Xiangyu Li
Lingjing Yuan

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2025.1689560

738 views

Original Research

Published on 07 Jan 2026

High-throughput identification of immunoreactive peptides and corresponding proteins from Anaplasma platys and Ehrlichia canis using peptide microarray chips

in Microbial Vaccines

Alejandro Llanes
Swetha Madesh
Kalvis Brangulis
Sreekumari Rajeev

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2025.1671309

818 views

Review

Published on 07 Jan 2026

Ex vivo mucosal cultures: an emerging player in vaccine development

in Microbial Vaccines

Nikita Chilakamarri
Erwan Sallard
Malik Aydin

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2025.1739617

1,114 views

Original Research

Published on 17 Dec 2025

Evaluation of the protective efficacy of a recombinant adenovirus-vectored SARS-CoV-2 vaccine candidate for veterinary use

in Microbial Vaccines

Chong Wang
Zhiyuan Wen
Gongxun Zhong
Lei Shuai
Chen Wang
Qilong Liu
Chenyu Ren
Jinying Ge
Xijun Wang
Jinliang Wang

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2025.1714427

1,462 views

Original Research

Published on 28 Nov 2025

Differential antioxidant enzyme profiles reveal early molecular signatures of virulence in Trypanosoma cruzi DTU-TcI and DTU-TcVI strains

in Microbial Vaccines

Edward Valencia Ayala
João Reis Cunha
Maritza Calderón Sánchez
Angela Giovanna Vidal Riva
Daniella Castanheira Bartholomeu
Alexandre Ferreira Marques

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2025.1664827

1,210 views

Editorial

Published on 19 Nov 2025

Editorial: Innovative vaccine strategies for enhanced flavivirus immunization

in Microbial Vaccines

Srinivasa Reddy Bonam
Nitin K. Saksena
Pedro A. Reche

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2025.1729523

1,080 views

Editorial

Published on 06 Nov 2025

Editorial: From bench to clinic: novel vaccines and therapeutics – “success stories”

in Microbial Vaccines

Arundhathi Venkatasubramaniam
Nathan K. Archer

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2025.1701460

1,341 views

Original Research

Accepted on 04 Nov 2025

Formulation and evaluation of a self-emulsifying emulsion as an effective adjuvant for inactivated foot-and-mouth disease vaccine in mice

in Microbial Vaccines

Dechun Xuan
Naiyan Sun
Zhi Li
Jianzhong Tang
Yanyan Zhao
Rong Fan
Yafang Xu
Haidong Wang
Cuiqin Huang
Jinqiu Zhang

Frontiers in Cellular and Infection Microbiology

427 views

Original Research

Published on 30 Oct 2025

Comparative safety evaluation of pentavalent (DTaP-IPV-Hib) and hexavalent (DTaP-IPV-Hib-HepB) vaccines in infants: a real-world analysis based on VAERS

in Microbial Vaccines

Zhen Wei
Bai Li
Hong-Ling Jia

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2025.1666509

2,501 views

Original Research

Published on 16 Oct 2025

LpxR and PagL expression in live attenuated auxotrophic Pseudomonas aeruginosa vaccines modulates lipid A reactogenicity in vitro while preserving immunogenicity

in Microbial Vaccines

Miriam Moscoso
Víctor Fuentes-Valverde
Patricia García
Juan A. Vallejo
Jesús Pérez-Ortega
Rebeca Santamarina-Fernández
Ana Candela
Marina Oviaño
Jesús Arenas
Germán Bou

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2025.1664169

2,029 views

Review

Published on 14 Oct 2025

Advances in diagnosis and treatment of lung cancer-associated obstructive pneumonia and lung abscess: synergistic strategies for infection control and antitumor therapy

in Microbial Vaccines

Peijun Cao
Li Chen
Shaohua Xie
Bin Hu

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2025.1638997

2,893 views

Original Research

Published on 26 Aug 2025

Post-marketing safety surveillance of pneumococcal vaccines: a real-world pharmacovigilance study using the U.S. vaccine adverse event reporting system (VAERS) database

in Microbial Vaccines

Xinkuo Zheng
Meishen Liu
Aili Ding
Shihong Zhang
Ling Wu
Fanli Kong
Weijia Sun
Yuchen Peng
Yalin Xi

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2025.1635180

4,475 views

Review

Published on 28 Jul 2025

Advances in nanotechnology for the therapy of bacterial pneumonia

in Microbial Vaccines

Zihan Tian
Yuwei Zhang
Jiachen Yun
Weihong Kuang
Jin Li

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2025.1639783

4,556 views
1 citation

Original Research

Published on 27 Jun 2025

Intranasal trivalent candidate vaccine elicits broad humoral and cellular immunity against pneumococcal pneumonia

in Microbial Vaccines

Fangyu Ren
Luyun Huang
Shilu Luo
Changjin Liu
Xianlian Chen
Xin Yao
Qiqi Linghu
Huaqin Hu
Xiaoyu Huang
Yuanqin Hu

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2025.1563661

2,839 views

Review

Published on 16 Jun 2025

Overcoming dengue vaccine challenges through next-generation virus-like particle immunization strategies

in Microbial Vaccines

Mariana Parra-González
Lucio Nájera-Maldonado
Esperanza Peralta-Cuevas
Ashley J. Gutierrez-Onofre
Igor Garcia-Atutxa
Francisca Villanueva-Flores

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2025.1614805

7,494 views
8 citations

Original Research

Published on 10 Jun 2025

Real-world pharmacovigilance reports of hepatitis A inactivated and hepatitis B (recombinant) vaccine: insights from disproportionality analysis of the vaccine adverse event reporting system

in Microbial Vaccines

Yuhang Zhou
Yue Wang
Yun Feng
Huiyue Zhang
Tao Sun
Junnan Xu

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2025.1609409

3,556 views
1 citation

Original Research

Published on 13 May 2025

Chlamydia muridarum mutant CM-pGP3S as a novel attenuated live rectal vaccine protects against genital tract infection

in Microbial Vaccines

Jingyue Ma
Tianyuan Zhang
Qi Tian
Meng Xiao
Long Han
Quanzhong Liu
Guangming Zhong
Yuanjun Liu

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2025.1550455

2,175 views

Review

Published on 25 Apr 2025

Revolutionizing Lyme disease vaccination: a systematic review and meta-analysis of promising candidates

in Microbial Vaccines

Sadia Tamanna
Dong-Min Kim

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2025.1554360

5,326 views
2 citations

Original Research

Published on 07 Feb 2025

The Mycoplasma hyopneumoniae protein Mhp274 elicits mucosal and systemic immune responses in mice

in Microbial Vaccines

Mengqi Xie
Zhongshun Huang
Yun Zhang
Yujie Gan
Huiying Li
Dan Li
Honglei Ding

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2025.1516944

3,777 views
3 citations

Original Research

Published on 07 Feb 2025

Systematic collection, annotation, and pattern analysis of viral vaccines in the VIOLIN vaccine knowledgebase

in Microbial Vaccines

Anthony Huffman
Mehul Gautam
Arya Gandhi
Priscilla Du
Lauren Austin
Kallan Roan
Jie Zheng
Yongqun He

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2025.1509226

3,201 views
3 citations

Review

Published on 20 Jan 2025

Computational biology and artificial intelligence in mRNA vaccine design for cancer immunotherapy

in Microbial Vaccines

Saber Imani
Xiaoyan Li
Keyi Chen
Mazaher Maghsoudloo
Parham Jabbarzadeh Kaboli
Mehrdad Hashemi
Saloomeh Khoushab
Xiaoping Li

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2024.1501010

22,886 views
45 citations

Editorial

Published on 26 Jul 2024

Editorial: Novel approaches for developing vaccines against influenza virus

in Microbial Vaccines

Rishi Kumar Jaiswal
Srijani Basu

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2024.1435768

3,089 views

49 articles

articles

A computational pipeline to discover potential cross-reactive antibodies: a case study on coronavirus

Diphtheria-tetanus-acellular pertussis vaccine safety in children under 7 years: a post-marketing analysis of the U.S. vaccine adverse event reporting system

Risk signal assessment of Tdap vaccine use alone by pregnant women: An updated pharmacoepidemiological study

High-throughput identification of immunoreactive peptides and corresponding proteins from Anaplasma platys and Ehrlichia canis using peptide microarray chips

Ex vivo mucosal cultures: an emerging player in vaccine development

Evaluation of the protective efficacy of a recombinant adenovirus-vectored SARS-CoV-2 vaccine candidate for veterinary use

Differential antioxidant enzyme profiles reveal early molecular signatures of virulence in Trypanosoma cruzi DTU-TcI and DTU-TcVI strains

Editorial: Innovative vaccine strategies for enhanced flavivirus immunization

Editorial: From bench to clinic: novel vaccines and therapeutics – “success stories”

Formulation and evaluation of a self-emulsifying emulsion as an effective adjuvant for inactivated foot-and-mouth disease vaccine in mice

Comparative safety evaluation of pentavalent (DTaP-IPV-Hib) and hexavalent (DTaP-IPV-Hib-HepB) vaccines in infants: a real-world analysis based on VAERS

LpxR and PagL expression in live attenuated auxotrophic Pseudomonas aeruginosa vaccines modulates lipid A reactogenicity in vitro while preserving immunogenicity

Advances in diagnosis and treatment of lung cancer-associated obstructive pneumonia and lung abscess: synergistic strategies for infection control and antitumor therapy

Post-marketing safety surveillance of pneumococcal vaccines: a real-world pharmacovigilance study using the U.S. vaccine adverse event reporting system (VAERS) database

Advances in nanotechnology for the therapy of bacterial pneumonia

Intranasal trivalent candidate vaccine elicits broad humoral and cellular immunity against pneumococcal pneumonia

Overcoming dengue vaccine challenges through next-generation virus-like particle immunization strategies

Real-world pharmacovigilance reports of hepatitis A inactivated and hepatitis B (recombinant) vaccine: insights from disproportionality analysis of the vaccine adverse event reporting system

Chlamydia muridarum mutant CM-pGP3S as a novel attenuated live rectal vaccine protects against genital tract infection

Revolutionizing Lyme disease vaccination: a systematic review and meta-analysis of promising candidates

The Mycoplasma hyopneumoniae protein Mhp274 elicits mucosal and systemic immune responses in mice

Systematic collection, annotation, and pattern analysis of viral vaccines in the VIOLIN vaccine knowledgebase

Computational biology and artificial intelligence in mRNA vaccine design for cancer immunotherapy

Editorial: Novel approaches for developing vaccines against influenza virus